Efficacy of Coenzyme Q10 in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled parallel-group comparative study

Efficacy of Coenzyme Q10 in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled parallel-group comparative study - Efficacy of Coenzyme Q10 in type 2 diabetes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015714

Enrollment

200

Registered

2014-11-18

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese patients with type 2 diabetes

Interventions

200mg Coenzyme Co10 placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 6.1< HbA1c < 8.5

Exclusion criteria

Exclusion criteria: 1. HbA1c > 8.5 2. Patients who have already taken CoQ10. 3. Sever liver, kidney, heart disease 4. Allergic to CoQ10 5. Patients who have already enrolled in other clinical study within 3 months. 6. pregnant and nursing women 7. Inadequate who is judged by doctor 8. patients with insulin therapy

Design outcomes

Primary

Measure	Time frame
Change in HbA1c	—

Secondary

Measure	Time frame
Fasting blood glucose, insulin, glucagon, GA, 1,5 AG	—

Countries

Japan

Contacts

Public ContactHideki Hanaoka

Chiba University Hospital Clinical Research center

shiken@office.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026